FLUCELVAX TETRA

This brand name is authorized in Austria, Brazil, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Poland, United Kingdom

Active ingredients

The drug FLUCELVAX TETRA contains a combination of these active pharmaceutical ingredients (APIs):

1 A/Wisconsin/67/2022 (H1N1)pdm09-like strain (A/Georgia/12/2022 CVR-167)

Read about Influenza, inactivated, surface antigen

2 A/Darwin/6/2021 (H3N2)-like strain (A/Darwin/11/2021, wild type)

Read about Influenza, inactivated, surface antigen

3 B/Austria/1359417/2021-like strain (B/Singapore/WUH4618/2021, wild type)

Read about Influenza, inactivated, surface antigen

4 B/Phuket/3073/2013-like strain (B/Singapore/INFTT-16-0610/2016, wild type)

Read about Influenza, inactivated, surface antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BB02	Influenza, purified antigen	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502620090009907, 502620090010007, 502620090010107
Country: EE	Ravimiamet	Identifier(s): 1786462, 1800717
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1181325001
Country: FR	Base de données publique des médicaments	Identifier(s): 60590648
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 365091, 365109
Country: IT	Agenzia del Farmaco	Identifier(s): 047475013, 047475025, 047475037, 047475049
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1086875, 1088039, 1088040, 1089826
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100416499